Tumor infiltrating lymphocytes (TILs) before and after neoadjuvant chemoradiotherapy and its clinical utility for rectal cancer.
about
A phase I/II trial of fixed-dose stereotactic body radiotherapy with sequential or concurrent pembrolizumab in metastatic urothelial carcinoma: evaluation of safety and clinical and immunologic responseDefinitive chemoradiation alters the immunologic landscape and immune checkpoints in head and neck cancer.Expressions of CD8+TILs, PD-L1 and Foxp3+TILs in stage I NSCLC guiding adjuvant chemotherapy decisions.Identification of a five B cell-associated gene prognostic and predictive signature for advanced glioma patients harboring immunosuppressive subtype preference.Rational bases for the use of the Immunoscore in routine clinical settings as a prognostic and predictive biomarker in cancer patients.Assessing Tumor-Infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method from the International Immuno-Oncology Biomarkers Working Group: Part 2: TILs in Melanoma, Gastrointestinal Tract CaDensity of CD8+ lymphocytes in biopsy samples combined with the circulating lymphocyte ratio predicts pathologic complete response to chemoradiotherapy for rectal cancer.Immunogenomic Classification of Colorectal Cancer and Therapeutic Implications.Tumor-infiltrating Lymphocytes Predict the Chemotherapeutic Outcomes in Patients with Stage IV Colorectal Cancer.The significance of tumor-infiltrating lymphocytes before and after neoadjuvant therapy for rectal cancer.A new method for evaluating tumor-infiltrating lymphocytes (TILs) in colorectal cancer using hematoxylin and eosin (H-E)-stained tumor sections.A comparison of the local immune status between the primary and metastatic tumor in colorectal cancer: a retrospective study.Immune interconnectivity of anatomically distant tumors as a potential mediator of systemic responses to local therapy.How many diseases is triple negative breast cancer: the protagonism of the immune microenvironment.Verification of the methodology for evaluating tumor-infiltrating lymphocytes in colorectal cancer.The prognostic value of combining the CD8 + lymphocyte density and the circulating lymphocyte ratio in circumferential resection margin biopsy in rectal cancerInhibiting the CD8 T cell infiltration in the tumor microenvironment after radiotherapy is an important mechanism of radioresistance
P2860
Q32177609-525633D9-AFCA-4B78-8459-28FD9AE4E42DQ37100703-1CC5C580-EC68-4764-B474-F00DD48D70E6Q37665660-F70A5541-4BF6-44A3-9F2D-EB4B91ED59D9Q37687506-FD5A43B9-E470-471D-A62F-A5C5E3962C12Q38819190-8DC34092-AA25-44F8-A714-57F16E895571Q46540302-6D69A9CB-1852-41E0-A934-70798F1B825AQ47108227-1C17FD45-D227-40AE-803F-8FC3E4FA9B7BQ47323319-35A5DF33-C9A3-43E8-84E6-E72A6040A8ACQ48529729-0EC9CCCF-2FE2-463C-9175-E2A9D7CC64F6Q49719408-2EBD7390-F5E6-47ED-AC59-A3201806C250Q52561263-99733777-AF1B-43E7-9FD4-BB4FB059A89DQ55091056-BD69BB5D-BB84-4B31-A438-D81DC4A5D7F1Q55285127-8586B0F1-614B-401E-B2A2-FBCEC2C81944Q55316580-4CBD50F9-A913-4DA8-BADC-B61764BC66D3Q55385663-B057A7EA-C85E-4255-8A56-81EC66613969Q58706845-D78DF3FC-EA21-4EE9-BE19-9FBF09D73D97Q58793793-26D7C711-C024-4694-8BA5-622C1D600961
P2860
Tumor infiltrating lymphocytes (TILs) before and after neoadjuvant chemoradiotherapy and its clinical utility for rectal cancer.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Tumor infiltrating lymphocytes ...... cal utility for rectal cancer.
@ast
Tumor infiltrating lymphocytes ...... cal utility for rectal cancer.
@en
type
label
Tumor infiltrating lymphocytes ...... cal utility for rectal cancer.
@ast
Tumor infiltrating lymphocytes ...... cal utility for rectal cancer.
@en
prefLabel
Tumor infiltrating lymphocytes ...... cal utility for rectal cancer.
@ast
Tumor infiltrating lymphocytes ...... cal utility for rectal cancer.
@en
P2093
P2860
P1476
Tumor infiltrating lymphocytes ...... cal utility for rectal cancer.
@en
P2093
Dianbin Mu
Feifei Teng
Jianbo Zhang
Jinming Yu
Sujing Liu
Xiangjiao Meng
P2860
P304
P577
2015-05-15T00:00:00Z